MedPath

Apraclonidine

Generic Name
Apraclonidine
Brand Names
Iopidine
Drug Type
Small Molecule
Chemical Formula
C9H10Cl2N4
CAS Number
66711-21-5
Unique Ingredient Identifier
843CEN85DI

Overview

Apraclonidine, also known as iopidine, is a sympathomimetic used in glaucoma therapy. It is an alpha2-adrenergic agonist.

Background

Apraclonidine, also known as iopidine, is a sympathomimetic used in glaucoma therapy. It is an alpha2-adrenergic agonist.

Indication

For prevention or reduction of intraoperative and postoperative increases in intraocular pressure (IOP) before and after ocular laser surgery when used prophylactically. Also used as a short-term adjunctive therapy in patients with open-angle glaucoma who are on maximally tolerated medical therapy requiring additional IOP reduction.

Associated Conditions

  • Ocular Hypertension
  • Postsurgical ocular hypertension

FDA Approved Products

IOPIDINE 1%
Manufacturer:Harrow Eye, LLC
Route:OPHTHALMIC
Strength:10 mg in 1 mL
Approved: 2023/07/31
NDC:82667-200
Apraclonidine
Manufacturer:Sandoz Inc
Route:OPHTHALMIC
Strength:5.75 mg in 1 mL
Approved: 2019/07/25
NDC:61314-665
Apraclonidine Ophthalmic
Manufacturer:Akorn
Route:OPHTHALMIC
Strength:5 mg in 1 mL
Approved: 2009/02/01
NDC:17478-716
IOPIDINE
Manufacturer:Alcon Laboratories, Inc.
Route:OPHTHALMIC
Strength:10 mg in 1 mL
Approved: 2018/12/21
NDC:0065-0660

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath